Search - tctmd.com

Displaying 101 - 120 of 239

Sort: Relevancy | Date

News Daily News

Non-HDL Cholesterol Strongly Tied to Lifetime CVD Risk

Michael O'Riordan

December 03, 2019

News Conference News VEITH 2019

More Real-world Data Support Safety of Paclitaxel-Based Devices in PAD

L.A. McKeown

November 22, 2019

News Conference News AHA 2019

Inclisiran Slashes LDL in ASCVD Patients: ORION-10

Yael L. Maxwell

November 16, 2019

News Daily News

Evolocumab Safe and Effective Out to 5 Years: OSLER-1

Yael L. Maxwell

October 22, 2019

News Daily News

Statins Started in Kids With FH Provide Benefits in Adulthood

Yael L. Maxwell

October 17, 2019

News Daily News

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

Caitlin E. Cox

October 16, 2019

News Daily News

Recurrent Events Common Among Young Patients With CAD

Michael O'Riordan

October 11, 2019

News Conference News ESC 2019

Young MI Patients’ Ischemic Risk Extends at Least Two Decades

Caitlin E. Cox

September 06, 2019

News Conference News ESC 2019

Long-term Secondary Prevention Post-CABG Important Yet Lacking: SWEDEHEART

Yael L. Maxwell

September 04, 2019

ORION-11: Inclisiran Shows Promise, Safety in Largest Published Cohort

News Conference News ESC 2019

ORION-11: Inclisiran Shows Promise, Safety in Largest Cohort to Date

Yael L. Maxwell

September 03, 2019

News Conference News SCCT 2019

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

Yael L. Maxwell

July 18, 2019

News Daily News

Familial Hypercholesterolemia Seen in 10% of Young MI Patients

Michael O'Riordan

May 15, 2019

News Daily News

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

L.A. McKeown

April 03, 2019

News Conference News ACC 2019

Under 40, or 10 Years Older: MI Survivors Face Similar Long-term Mortality Risks

Todd Neale

March 07, 2019

News Daily News

Lower Statin Adherence Linked to Higher Mortality Risk, Even Among Patients With Established ASCVD

Lucy Hicks

February 15, 2019

News Daily News

Abnormal Coronary Reactivity in Women Portends Added CV, Death Risk in the Next Decade

Caitlin E. Cox

February 13, 2019

News Daily News

Age Shouldn’t Be a Barrier to Statin Therapy, Meta-analysis Suggests

Michael O'Riordan

February 08, 2019

News Daily News

Nicardipine Alleviates ‘Slow Flow’ in Chest-Pain Patients Without Obstructive CAD

Michael O'Riordan

January 03, 2019

News Conference News VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

L.A. McKeown

November 15, 2018

News Conference News AHA 2018

New Cholesterol Guidelines Make Room for Non-Statin Therapy and CAC Screening

Michael O'Riordan

November 10, 2018

Advertisement

Non-HDL Cholesterol Strongly Tied to Lifetime CVD Risk

More Real-world Data Support Safety of Paclitaxel-Based Devices in PAD

Inclisiran Slashes LDL in ASCVD Patients: ORION-10

Evolocumab Safe and Effective Out to 5 Years: OSLER-1

Statins Started in Kids With FH Provide Benefits in Adulthood

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

Recurrent Events Common Among Young Patients With CAD

Young MI Patients’ Ischemic Risk Extends at Least Two Decades

Long-term Secondary Prevention Post-CABG Important Yet Lacking: SWEDEHEART

ORION-11: Inclisiran Shows Promise, Safety in Largest Cohort to Date

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

Familial Hypercholesterolemia Seen in 10% of Young MI Patients

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

Under 40, or 10 Years Older: MI Survivors Face Similar Long-term Mortality Risks

Lower Statin Adherence Linked to Higher Mortality Risk, Even Among Patients With Established ASCVD

Abnormal Coronary Reactivity in Women Portends Added CV, Death Risk in the Next Decade

Age Shouldn’t Be a Barrier to Statin Therapy, Meta-analysis Suggests

Nicardipine Alleviates ‘Slow Flow’ in Chest-Pain Patients Without Obstructive CAD

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

New Cholesterol Guidelines Make Room for Non-Statin Therapy and CAC Screening

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content